Age (years), mean ± SD
|
73.8 ± 6.4
|
73.8 ± 6.5
|
70.5 ± 5.8
|
0.809
|
Sex, males/females
|
34/23
|
27/23
|
7/0
|
0.034
|
Albumin (g/dL), mean ± SD
|
2.8 ± 0.6
|
2.7 ± 0.4
|
3.65 ± 0.2
|
<.001
|
BMI (kg/m2), mean ± SD
|
20.8 ± 3.1
|
20.6 ± 3.2
|
22.1 ± 2.4
|
0.016
|
GNRI, mean ± SD
|
79.8 ± 9.9
|
77.6 ± 8.3
|
96.0 ± 1.9
|
<.001
|
CRP (mg/dL), median (IQR)
|
3.365 (0.98–7.742)
|
3.797 (1.621–9.847)
|
0.441 (0.235–1.863)
|
0.014
|
BI at baseline, median (IQR)
|
35 (10–60)
|
35 (11.25–60)
|
30 (7.5–45)
|
0.750
|
BI at discharge, median (IQR)
|
70 (30–90)
|
65 (25–90)
|
85 (77.5–92.5)
|
0.121
|
BI gain, median (IQR)
|
15 (0–30)
|
10 (0–30)
|
50 (25–85)
|
0.027
|
Length of stay (days), median (IQR)
|
37 (22–52)
|
38.5 (23.25–51.25)
|
29 (19.5–44)
|
0.436
|
Days from A to R (days), median (IQR)
|
8 (5–14)
|
9 (6–14)
|
7 (3–8.5)
|
0.065
|
Duration of rehabilitation (days), median (IQR)
|
27 (15–36)
|
27 (15–36)
|
25 (15–35.5)
|
0.855
|
Duration of hemodialysis (years), median (IQR)
|
7 (6–12)
|
7 (3–13)
|
6 (1–7)
|
0.200
|
Causative disease for admission (n)
|
Ischemic heart disease
|
10
|
9
|
1
| |
Aortic disease
|
4
|
4
| | |
Valvular disease of the heart
|
4
|
4
| | |
Congestive heart failure
|
3
|
3
| | |
Cerebral infarction
|
7
|
3
|
4
| |
Parkinson’s disease
|
1
| |
1
| |
Lumbar disease
|
6
|
6
| | |
Fracture
|
3
|
3
| | |
Osteoarthritis
|
3
|
3
| | |
Psychiatric disease
|
3
|
2
|
1
| |
Perforation of the digestive tract
|
2
|
2
| | |
Pneumonia
|
2
|
2
| | |
Shunt complication
|
2
|
2
| | |
Other
|
7
|
7
| | |
Etiology of chronic kidney disease (n)
|
Diabetic nephropathy
|
30
|
27
|
3
| |
Nephrosclerosis
|
9
|
6
|
3
| |
Chronic glomerulonephritis;
|
6
|
6
| | |
Multiple renal cysts
|
3
|
2
|
1
| |
Rapidly progressive glomerulonephritis
|
1
|
1
| | |
SLE nephritis
|
1
|
1
| | |
Nephronophthisis
|
1
|
1
| | |
Chronic pyelonephritis
|
1
|
1
| | |
Drug-induced kidney injury
|
1
|
1
| | |
Renal infarction
|
1
|
1
| | |
Unknown
|
3
|
3
| | |